Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Name : Erlotinib
Shape : White crystalline powder
Second-line treatment for locally advanced or metastatic non-small cell lung cancer.It has been approved by FDA for use in combination with gemcitabine as a first-line treatment for advanced pancreatic cancer.
Erlotinib is indicated for second-line treatment of locally advanced or metastatic non-small cell lung cancer.It is mainly metabolized by the liver, with 83% excreted in feces and 8% excreted in urine.
Name | CAS | molecular | density |
Erlotinib | 183321-74-6 | C22H23N3O4 | 1.24 |